Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,220 Jan 1 – Oct 25, 2026
- Disclosed funding
- $248.4B 1843 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B BANDCompany profile Builds interaction infrastructure for distributed AI agents enabling real-time collaboration Builds interaction infrastructure for distributed AI agents enabling real-time collaboration | $17M | Seed | AI | United States | Investors | |
 Amperos HealthCompany profile Amperos Health combines AI collections workflows and revenue-cycle specialists to recover unpaid insurance claims for healthcare providers. Amperos Health combines AI collections workflows and revenue-cycle specialists to recover unpaid insurance claims for healthcare providers. | $16M | Series A | Healthtech | United States | Investors | |
| A AaruCompany profile Aaru develops synthetic-population simulations to help organizations test products, messages and strategic decisions. Aaru develops synthetic-population simulations to help organizations test products, messages and strategic decisions. | $80M | Series A | AI | United States | Investors | |
| M Builds AI-driven deal modeling platform for private markets | $18M | Series A | Fintech | United States | Investors | |
| II IGCS InternationalCompany profile Provides mission support and MRO supplies to the U.S. Department of Defense and federal agencies Provides mission support and MRO supplies to the U.S. Department of Defense and federal agencies | Undisclosed | StrategicUndisclosed | Defense tech | United States | Investors | |
| S Provides runtime monetization infrastructure for SaaS and AI companies | $6.5M | Undisclosed | Fintech | United States | Investors | |
| CH Manages patient experiences for biopharma patients | $50M | Series B | Healthtech | United States | Investors | |
| N NephronomicsCompany profile Develops AI-driven precision medicine for cardio-kidney-metabolic disease Develops AI-driven precision medicine for cardio-kidney-metabolic disease | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| DB Develops surgical devices for soft tissue surgery | $5.6M | Series A | Healthtech | United States | Investors Undisclosed | |
| S Builds autonomous full-stack red teaming platform with AI agents | Undisclosed | Seed | Cybersecurity | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
132rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Tractian, Different, Baba
69rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
58rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.